Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Regardless of breast density or HT use, women aged 50 to 74 years can undergo biennial mammography

A study that compared the benefits and harms of the frequency of screening mammography to age, breast density and postmenopausal use of hormone therapy (HT) suggests that woman ages 50 to 74 years who undergo biennial screenings have a similar risk of advanced-stage disease and a lower cumulative risk of false-positive results than those who get mammograms annually, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.

19 Mar 2013

Digital rectal exam important for prostate screening, researchers say

The digital rectal exam is an important screening test that can discover prostate cancer that a prostate-specific antigen or PSA test may not, despite the higher sensitivity of the PSA test, according to Penn State College of Medicine researchers.

19 Mar 2013

Researchers report development of multi-parameter sorting approach to part SSCs from cancerous cells

As success rates in treating childhood cancers have improved, greater emphasis is being placed on quality of life issues following successful treatment.

18 Mar 2013

Genetic score based on PCa risk-associated SNPs predicts prostate biopsy outcomes: Study

A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.

16 Mar 2013

MGH investigators identify new disease that causes widespread chronic pain in children

Massachusetts General Hospital (MGH) investigators have described what may be a newly identified disease that appears to explain some cases of widespread chronic pain and other symptoms in children and young adults.

13 Mar 2013

Mummies provide important twist in understanding atherosclerotic vascular disease

Like nearly 4.6 million Americans, ancient hunter-gatherers also suffered from clogged arteries, revealing that the plaque build-up causing blood clots, heart attacks and strokes is not just a result of fatty diets or couch potato habits, according to new research in the journal The Lancet.

11 Mar 2013

Research: Stringent criteria for surveillance of prostate cancer needed for African Americans

New research from The Cancer Institute of New Jersey suggests that more stringent criteria may be needed for African American men with prostate cancer when considering active surveillance of the disease.

11 Mar 2013

Weill Cornell receives NIMH grant to discover novel biomarkers for chronic fatigue syndrome

Weill Cornell Medical College has been awarded more than $1.9 million by the National Institute of Mental Health of the National Institutes of Health to lead an innovative research study using advanced neuroimaging and clinical evaluations of patients with chronic fatigue syndrome (CFS).

8 Mar 2013

Prostate tissue androgen content predicts ADT outcome

Determining the androgen content in prostate tissue could predict patients’ responses to androgen deprivation therapy and the risk for castration-resistant prostate cancer, show study findings.

6 Mar 2013

Focal laser ablation uses targeted heat to burn away cancerous cells in prostate

Men with low-risk prostate cancer who previously had to choose between aggressive treatment, with the potential for significant side effects, and active surveillance, with the risk of disease progression, may have a new option.

6 Mar 2013

Screening colonoscopy associated with reduced advanced colorectal cancer diagnoses

A new study led by a researcher at the Perelman School of Medicine at the University of Pennsylvania adds support to current medical recommendations stating that screening colonoscopy substantially reduces an average-risk adult's likelihood of being diagnosed with advanced colorectal cancer (CRC) in either the right or left side of the colon.

4 Mar 2013

Study finds how to shut down Bcl6 in diffuse large B-cell lymphoma

The powerful master regulatory transcription factor called Bcl6 is key to the survival of a majority of aggressive lymphomas, which arise from the B-cells of the immune system. The protein has long been considered too complex to target with a drug since it is also crucial to the healthy functioning of many immune cells in the body, not just B cells gone bad.

4 Mar 2013

EORTC survey looks at common practices in melanoma surgery

The European Organisation for Research and Treatment of Cancer (EORTC) has conducted an international survey of 75 melanoma centres on their behaviours and practices. The survey, which was conducted between 2003-2005, looked at common surgical practices in melanoma surgery (resection margins, sentinel node biopsy and lymph node dissection), as well as surgical management of distant metastases and the use of Isolate Limb Perfusion.

1 Mar 2013

Trends in patient worry and risk-reducing behaviors in women undergoing breast cancer treatment

Women who have had the lymph nodes under their arm surgically removed during breast cancer treatment are warned to avoid certain practices that can cause lymphedema-a condition that causes chronic, painless swelling in the arm.

26 Feb 2013

Researchers improve NanoVelcro device to better grab cancer cells as blood passes by them

Researchers at UCLA report that they have refined a method they previously developed for capturing and analyzing cancer cells that break away from patients' tumors and circulate in the blood. With the improvements to their device, which uses a Velcro-like nanoscale technology, they can now detect and isolate single cancer cells from patient blood samples for analysis.

26 Feb 2013

Leading cancer researcher, Dr. Lewis Cantley, named a winner of the inaugural Breakthrough Prize in Life Sciences

Dr. Lewis Cantley, a leading cancer researcher credited with discovering a family of enzymes fundamental to understanding cancer, was named a winner of the inaugural Breakthrough Prize in Life Sciences, the world’s richest academic prize for medicine and biology. The prize, which carries a $3 million cash award, recognizes excellence in research aimed at curing intractable diseases and human life.

22 Feb 2013

Researchers use 3D printing and injectable gels to create bioengineered ears

Physicians at Weill Cornell Medical College and biomedical engineers at Cornell University have succeeded in building a facsimile of a living human ear that looks and acts like a natural ear. Researchers believe their bioengineering method will finally succeed in the long quest by scientists and physicians to provide normal looking "new" ears to thousands of children born with a congenital ear deformity.

22 Feb 2013

Introducing gluten-containing foods to breast-feeding infants may prevent celiac disease

Celiac disease is much more common in Sweden than in the rest of Europe and the U.S., but may be prevented with gradually introducing gluten-containing foods to breast-feeding infants, according to a comprehensive study led by researchers at Umeå University.

20 Feb 2013

Possible alternative to biopsy discovered for renal cancer diagnosis

Combining positron emission tomography scanning with iodine-124 (124I)–girentuximab may offer an effective noninvasive method of diagnosing clear cell renal cell carcinoma in patients who present with a renal mass, US study results suggest.

20 Feb 2013

Predictive value of prostate cancer gene 3 validated

Researchers have confirmed that the prostate cancer gene 3 is a valid predictor for current cancer and future biopsy outcomes.

20 Feb 2013

Biopsy News and Research

Further Reading

Regardless of breast density or HT use, women aged 50 to 74 years can undergo biennial mammography

Digital rectal exam important for prostate screening, researchers say

Researchers report development of multi-parameter sorting approach to part SSCs from cancerous cells

Genetic score based on PCa risk-associated SNPs predicts prostate biopsy outcomes: Study

MGH investigators identify new disease that causes widespread chronic pain in children

Mummies provide important twist in understanding atherosclerotic vascular disease

Research: Stringent criteria for surveillance of prostate cancer needed for African Americans

Weill Cornell receives NIMH grant to discover novel biomarkers for chronic fatigue syndrome

Prostate tissue androgen content predicts ADT outcome

Focal laser ablation uses targeted heat to burn away cancerous cells in prostate

Screening colonoscopy associated with reduced advanced colorectal cancer diagnoses

Study finds how to shut down Bcl6 in diffuse large B-cell lymphoma

EORTC survey looks at common practices in melanoma surgery

Trends in patient worry and risk-reducing behaviors in women undergoing breast cancer treatment

Researchers improve NanoVelcro device to better grab cancer cells as blood passes by them

Leading cancer researcher, Dr. Lewis Cantley, named a winner of the inaugural Breakthrough Prize in Life Sciences

Researchers use 3D printing and injectable gels to create bioengineered ears

Introducing gluten-containing foods to breast-feeding infants may prevent celiac disease

Possible alternative to biopsy discovered for renal cancer diagnosis

Predictive value of prostate cancer gene 3 validated

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News